BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 23241370)

  • 21. Effect of HUVEC apoptosis inducing proteinase from Vipera lebetina venom (VLAIP) on viability of cancer cells and on platelet aggregation.
    Samel M; Trummal K; Siigur E; Siigur J
    Toxicon; 2012 Sep; 60(4):648-55. PubMed ID: 22781133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice.
    Suy S; Mitchell JB; Samuni A; Mueller S; Kasid U
    Cancer; 2005 Mar; 103(6):1302-13. PubMed ID: 15685617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth.
    Iljin K; Ketola K; Vainio P; Halonen P; Kohonen P; Fey V; Grafström RC; Perälä M; Kallioniemi O
    Clin Cancer Res; 2009 Oct; 15(19):6070-8. PubMed ID: 19789329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP.
    Engedal N; Korkmaz CG; Saatcioglu F
    Oncogene; 2002 Feb; 21(7):1017-27. PubMed ID: 11850819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP
    Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isosilybin B and isosilybin A inhibit growth, induce G1 arrest and cause apoptosis in human prostate cancer LNCaP and 22Rv1 cells.
    Deep G; Oberlies NH; Kroll DJ; Agarwal R
    Carcinogenesis; 2007 Jul; 28(7):1533-42. PubMed ID: 17389612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cathepsin E enhances anticancer activity of doxorubicin on human prostate cancer cells showing resistance to TRAIL-mediated apoptosis.
    Yasukochi A; Kawakubo T; Nakamura S; Yamamoto K
    Biol Chem; 2010 Aug; 391(8):947-58. PubMed ID: 20482316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel resveratrol derivatives induce apoptosis and cause cell cycle arrest in prostate cancer cell lines.
    Horvath Z; Marihart-Fazekas S; Saiko P; Grusch M; Ozsüy M; Harik M; Handler N; Erker T; Jaeger W; Fritzer-Szekeres M; Djavan B; Szekeres T
    Anticancer Res; 2007; 27(5A):3459-64. PubMed ID: 17970095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and anti-protozoal activity of C2-substituted polyazamacrocycles.
    Reid CM; Ebikeme C; Barrett MP; Patzewitz EM; Müller S; Robins DJ; Sutherland A
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2455-8. PubMed ID: 18313921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA demethylation and histone deacetylation inhibition co-operate to re-express estrogen receptor beta and induce apoptosis in prostate cancer cell-lines.
    Walton TJ; Li G; Seth R; McArdle SE; Bishop MC; Rees RC
    Prostate; 2008 Feb; 68(2):210-22. PubMed ID: 18092350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.
    Ben Sahra I; Laurent K; Loubat A; Giorgetti-Peraldi S; Colosetti P; Auberger P; Tanti JF; Le Marchand-Brustel Y; Bost F
    Oncogene; 2008 Jun; 27(25):3576-86. PubMed ID: 18212742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiproliferative effect in vitro and antitumor activity in vivo of brefeldin A.
    Sausville EA; Duncan KL; Senderowicz A; Plowman J; Randazzo PA; Kahn R; Malspeis L; Grever MR
    Cancer J Sci Am; 1996; 2(1):52-8. PubMed ID: 9166499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery and potency optimization of 2-amino-5-arylmethyl-1,3-thiazole derivatives as potential therapeutic agents for prostate cancer.
    Krasavin M; Karapetian R; Konstantinov I; Gezentsvey Y; Bukhryakov K; Godovykh E; Soldatkina O; Lavrovsky Y; Sosnov AV; Gakh AA
    Arch Pharm (Weinheim); 2009 Jul; 342(7):420-7. PubMed ID: 19544302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic tumor growth-inhibitory effect of the prostate-specific antigen-activated fusion peptide BSD352 for prostate cancer therapy.
    Li B; Zhang LJ; Zhang ZL; Long M; Ren JH; Lin F; Wang X; Wei JX; Dong K; Zhang HZ
    Anticancer Drugs; 2011 Mar; 22(3):213-22. PubMed ID: 21150773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbidopa enhances antitumoral activity of bicalutamide on the androgen receptor-axis in castration-resistant prostate tumors.
    Thomas C; Wafa LA; Lamoureux F; Cheng H; Fazli L; Gleave ME; Rennie PS
    Prostate; 2012 Jun; 72(8):875-85. PubMed ID: 22072572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of macrocyclic bisbibenzyl derivatives and their anticancer effects as anti-tubulin agents.
    Jiang J; Sun B; Wang YY; Cui M; Zhang L; Cui CZ; Wang YF; Liu XG; Lou HX
    Bioorg Med Chem; 2012 Apr; 20(7):2382-91. PubMed ID: 22365913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivo.
    Henry JY; Lu L; Adams M; Meyer B; Bartlett JB; Dalgleish AG; Galustian C
    Prostate; 2012 Jun; 72(8):856-67. PubMed ID: 21968939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
    Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC
    Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiandrogenic and growth inhibitory effects of ring-substituted analogs of 3,3'-diindolylmethane (ring-DIMs) in hormone-responsive LNCaP human prostate cancer cells.
    Abdelbaqi K; Lack N; Guns ET; Kotha L; Safe S; Sanderson JT
    Prostate; 2011 Sep; 71(13):1401-12. PubMed ID: 21321979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.